Scale Investors

The three General Partners — Samar Mcheileh (Managing Partner), Roo Harris, and Chelsea Newell — collectively manage investment decisions. Mcheileh steers strategy and thesis development from her JBWere institutional background, Harris contributes cross-border venture experience including work with Qatar's ruling family, and Newell oversees deal origination, due diligence processes, and investor onboarding. No investment committee beyond this trio is publicly identified.

Sourcing combines community-based network effects with structural thesis alignment. The firm's explicit mandate to back women-led startups draws founders likely to be overlooked by traditional Australian VC, while the co-created Equity Clear initiative — a gender transparency platform — reinforces network reach among female operators. GP involvement in accelerator and early-stage ecosystem events in Melbourne provides additional origination channels, though the firm does not publicly disclose exclusivity arrangements.

Scale Investors is a venture capital asset manager, not a family office. It pools capital from external investors through a syndicate structure — and likely a fund vehicle — rather than deploying a single-family balance sheet. The three general partners came to the firm from institutional advisory and wealth management careers, not from operating a family office or managing generational wealth.

Public disclosures describe only direct startup investments via a syndicate portfolio model, with checks at Seed, Start-up, and occasionally Expansion or Growth stages. No evidence indicates the firm makes LP commitments to external VC funds. The team structure and public deal flow suggest a direct-investing mandate rather than a fund-of-funds approach.

Equity Clear is a gender-transparency initiative co-created by Scale Investors and recognized on Fortune's "Change the World" list. While separate from the investment vehicle, it serves dual purposes: industry advocacy for gender-disaggregated funding data and a sourcing and brand mechanism that directs female-founder deal flow toward Scale's syndicate. The GPs participate actively in the initiative without Equity Clear taking a direct carried interest in portfolio companies.

The core mandate spans Early Stage categories: Seed and Start-up rounds form the bulk of public portfolio activity, with selective follow-on into Expansion and Late Stage Growth. The firm's portfolio ranges from pre-revenue companies like Baymatob (AI maternal monitoring) to revenue-generating businesses such as Vitable (personalized vitamin subscription), consistent with a flexible check-size approach rather than a rigid stage gate.

The firm does not publish an exclusion list. Its thesis centers on where women-led startups are outperforming but underfunded, which implicitly favors sectors where female founders have historically concentrated — healthcare, consumer tech, workforce platforms, and education — but the portfolio also spans industrial cybersecurity (HackHunter), agritech (Agscent), and insurtech (Handdii). There is no evidence of investments in extractive industries, defense, or crypto/web3 verticals.